Beijing's Kimi developer has run three funding rounds in six months, raising ~$3.9B as Chinese AI labs race to establish valuations before IPO windows open.
A Beijing startup just marked up its own valuation seven times in six months. Moonshot AI, developer of the Kimi chatbot, is in talks to raise up to $2 billion at a $30 billion valuation, The Next Web reported Sunday, citing Bloomberg. In December, the company was worth roughly $4 billion.
The sequence requires a second read. Moonshot is still closing a previous round led by Meituan, which pegged it at $20 billion. Before that closes, a third round has already opened. Three financings in six months, approximately $3.9 billion raised in total.
That pace is explained by the revenue curve. Moonshot's annual recurring revenue hit $200 million in April, up from $100 million at the start of March. Doubling in roughly seven weeks is the kind of signal that makes investors move before the next term sheet lands.
The race
China's artificial intelligence startup hierarchy is hardening around four names. DeepSeek, the most internationally recognized, is raising roughly $7 billion in its debut round at a valuation approaching $59 billion. Zhipu AI commands about $80 billion. MiniMax, which recently doubled its sales, trades near $20 billion in Hong Kong while eyeing a Shanghai listing. Moonshot at $30 billion fits neatly into third place.
The Next Web reports the four companies collectively seek valuations exceeding $180 billion. That still trails American peers by a wide margin, with OpenAI above $850 billion and Anthropic near $965 billion, but the compression is happening faster than most observers expected a year ago.
What separates Moonshot
DeepSeek built its reputation on research output and open-source model releases. Moonshot went the other direction: Kimi is a consumer product, and the $200 million ARR figure is a straight revenue story. There is no artificial intelligence index citation driving that number, just paying users. That distinction matters to investors separating durable businesses from hype-cycle plays.
The compressed fundraising schedule also reflects a sector-wide pressure: IPO windows. Chinese AI labs need established valuations and credible revenue metrics before public markets open. A company doubling ARR in two months enters any listing process with leverage. Three rounds in six months looks less like opportunism and more like deliberate runway-building.
The policy backdrop
Regulatory signals from Washington are contradictory. Six days before David Sacks, the former White House AI and Crypto adviser, publicly dismissed elevated safety concerns as "Hollywood storytelling" on X, President Trump signed an executive order asking companies to voluntarily submit powerful models for federal safety testing up to 30 days before release, Yahoo News reported. The gap between the signed document and the adviser's public commentary is difficult to ignore.
On the other side of that debate, Live Mint reported this weekend that Microsoft's responsible AI chief, Sarah Bird, told Indian policymakers that oversight builds trust without constraining innovation. Microsoft posted $3.38 billion in Indian revenue in FY25 and employs more than 23,000 people there. When a company that size advocates for regulation, artificial intelligence review starts to look less like a compliance cost and more like a competitive moat for incumbents who can absorb the overhead.
For Chinese labs, the regulatory calculus runs through Beijing rather than Washington. The companies racing toward $30 billion valuations are operating inside China's own governance structure, not around it.
What comes next
Moonshot still needs to close its Meituan-led round before the $30 billion target can be formalized. If both rounds close as discussed, total capital raised since December reaches roughly $3.9 billion, all while ARR doubled in under two months. That is an unusual sequence by any market's standards.
At current trajectories, the valuation gap between Chinese and American AI labs could look very different by the end of 2026, assuming IPO markets cooperate and revenue growth holds.
FAQ
What is Moonshot AI and what does Kimi do?
Moonshot AI is a Beijing-based artificial intelligence company. Its flagship product, Kimi, is a consumer chatbot competing with both domestic and international AI offerings. Kimi is the primary driver behind Moonshot's $200 million annual recurring revenue.
How does Moonshot AI compare to other Chinese AI companies?
Moonshot's $30 billion target would rank it third among Chinese AI labs, behind Zhipu AI (roughly $80 billion) and DeepSeek (up to $59 billion), and ahead of publicly listed MiniMax (about $20 billion in Hong Kong).
Why has Moonshot AI run three funding rounds in six months?
Chinese AI labs are under pressure to establish valuations and revenue track records before IPO windows open. Moonshot's fast-growing ARR creates leverage in each successive round, and investors appear willing to move quickly rather than wait for a lower entry price.
How does Moonshot AI's strategy differ from DeepSeek's?
DeepSeek has prioritized research output and open-source releases that earned global attention. Moonshot has focused on consumer product and commercial revenue, with Kimi as the primary growth vehicle.